Background/aims: The aim of this study is to share the results of gastric botulinum toxin (BTX) application in individuals who are overweight or type 1 obese without comorbidity.
Materials And Methods: In this study, 13 patients were included who were enrolled for gastric BTX application for the first time. A total of 300 U of BTX-A (Allergan Botox ®1 vial 100 U) was diluted with 8 mL of 0.9% NaCl saline, and antrum (100 U to 8 spots), corpus (100 U to 8 spots), and fundus (100 U to 8 spots) regions were injected intramuscularly. Patients were given a 1200-calorie low-carb diet and this was followed for 6 months.
Results: Gastric BTX application was applied to 13 patients with a mean age of 40.9 ± 5.2 (85% female), a mean body mass index (BMI) of 28.41 ± 1.4 kg/m2 (26-31.6) and a mean excess weight of 10.1 ± 3.6 kg. As a result of the 6-month follow-up, only four patients (30.8%) were able to lose more than 50% of their excess weight (6-15 kg). Six patients (46.2%) could not lose any weight. There was an average decrease of 3.3 kg in the weight of patients before and after BTX application (P = .03). A mean decrease of BMI was detected, 1.17 kg/m2 (P = .032).
Conclusion: It was concluded that the application of gastric BTX for weight loss does not provide effective results.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8975509 | PMC |
| http://dx.doi.org/10.5152/tjg.2020.20076 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Botulinum Toxin's Effects on Muscle Tone and Joint Mobility in Children with Congenital Zika Syndrome - A Case Series.
Rev Bras Ortop (Sao Paulo)
December 2024
Instituto de Pesquisa Professor Joaquim Amorim Neto (IPESQ), Campina Grande, PB, Brasil.
To evaluate the effects of the botulinum toxin (BTX-A) on muscle tone and joint mobility in children with congenital Zika syndrome (CZS). This was a longitudinal case series carried out in a Support Center for Children with Microcephaly, located in Northeastern Brazil. We collected data from the institution's medical records, containing information about muscle tone and passive joint mobility measured at least 3 months before and 4 weeks after BTX-A application.
View Article and Find Full Text PDFSimultaneous separation and detection of common chiral and achiral metabolites in the urine of human exposed to benzene series by LC-MS/MS.
J Chromatogr B Analyt Technol Biomed Life Sci
December 2024
School of Ecology and Environment, Yuzhang Normal University, No.1999, Meiling Ave., Honggutan Dist., Nanchang 330103, Jiangxi, China.
Benzene, toluene, and xylene (BTX) are priority pollutants known for their hematotoxicity and carcinogenic properties. Benzene is further metabolized to phenyl mercapturic acid (PMA), toluene and xylene also generate benzyl mercapturic acid (BMA) in human urine. To confirm whether the exposure to benzene series comes from the workplace or from the external environment such as smoking is a very meaningful work, so accurate measurement of their biomarkers in biological samples is crucial.
View Article and Find Full Text PDFMelasma Management: A Comprehensive Review of Treatment Strategies Including BTX-A.
J Cosmet Dermatol
November 2024
Skin Laser & Surgery Specialists, A Division of Schweiger Dermatology Group, New York, New York, USA.
Background: Botulinum toxin A (BTX-A) is a widely utilized protein derived from the bacterium Clostridium botulinum, known for its effectiveness in treating various medical conditions involving muscle spasticity, involuntary muscle movements, and pain disorders. Beyond its therapeutic applications, BTX-A is also commonly used in cosmetic procedures to address dynamic wrinkles, hyperhidrosis, sebum production, pore size, and overall skin texture. While the use of neurotoxins like BTX-A for treating conditions such as UVB-induced hyperpigmentation, specifically melasma, is an emerging area of interest, it is not yet a widely recognized treatment for this dermatologic condition.
View Article and Find Full Text PDFBotulinum toxin A for the treatment of neurogenic bladder in children: a systematic review and meta-analysis.
ANZ J Surg
November 2024
Department of Pediatric Surgery, Hangzhou Children's Hospital, Hangzhou, Zhejiang, China.
Article Synopsis
- A systematic review and meta-analysis were conducted to evaluate the efficacy of botulinum toxin A (BTX-A) injections in children with neurogenic bladder (NB) who do not respond to traditional antimuscarinic treatments.
- The review examined 19 studies, highlighting significant improvements, such as a 97.7 mL increase in cystometric capacity, a decrease in detrusor pressure by 25.2 cm HO, and a 73.4% incontinence resolution rate post-treatment.
- However, the studies varied in quality and design, lacking a placebo comparison and control groups, indicating that the evidence for BTX-A's effectiveness is not firmly established.
Fabrication of surface functionalized QCM sensor for BTX detection at ambient conditions.
Talanta
February 2025
Department of Instrumentation & Electronics Engg., Jadavpur University, Salt Lake Campus Block LB, Kolkata 700106, India. Electronic address:
Article Synopsis
- - The study focuses on creating efficient gas sensors using Quartz Crystal Microbalance (QCM) coated with Tungsten Oxide (WO) to detect harmful BTX compounds (Benzene, Toluene, and Xylene) in the environment.
- - Various scientific methods such as Optical Profilometry, Scanning Electron Microscopy, and X-ray Diffraction were used to analyze the sensor's surface and structure, revealing an optimal film thickness of about 200.81 nm with a granular microstructure.
- - The developed sensor demonstrated high sensitivity, with the best response to xylene (5.10 Hz/ppm), quick response times, and impressive repeatability (99%) and reproducibility (98%), making it a promising
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!